Equity (Details - Warrant Activity) - Warrants [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
| Warrants outstanding, shares | 4,133,252 | 140,512 |
| Warrants outstanding, weighted average exercise price per share | $ 4.35 | $ 142.83 |
| Warrants granted, shares | 3,849,900 | 4,237,900 |
| Warrants granted, weighted average exercise price per share | $ 1.29 | $ 2.88 |
| Warrants exercised, shares | (3,741,958) | (204,957) |
| Warrants exercised, weighted average exercise price per share | $ 0.84 | $ 0.01 |
| Warrants forfeited, shares | 0 | 0 |
| Warrants forfeited, weighted average exercise price per share | $ 0 | $ 0 |
| Warrants expired, shares | (1,131) | (40,203) |
| Warrants expired, weighted average exercise price per share | $ 30.91 | $ 330.00 |
| Warrants outstanding, shares | 4,240,063 | 4,133,252 |
| Warrants outstanding, weighted average exercise price per share | $ 3.88 | $ 4.35 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|